Eyenovia, Inc. (NASDAQ:EYEN) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET
Company Participants
Eric Ribner - IR
Michael Rowe - CEO
Bren Kern - COO
Andy Jones - CFO
Conference Call Participants
Matthew Caufield - H.C. Wainwright
Matt Kaplan - Ladenburg Thalmann
Lachlan Hanbury-Brown - William Blair
Kemp Dolliver - Brookline Capital Markets
Len Yaffe - Stoc Doc Partners
Operator
Greetings and welcome to Eyenovia's Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host Eric Ribner, Investor Relations. Thank you. You may begin.
Eric Ribner
Good afternoon and welcome to Eyenovia's third quarter 2024 earnings conference call and audio webcast. With me today are Eyenovia's Chief Executive Officer, Michael Rowe; Chief Operating Officer, Bren Kern; and new appointed Chief Financial Officer, Andy Jones. Welcome everybody.
This afternoon, we issued a press release announcing financial results for the three months ended September 30th, 2024. We encourage everyone to read today's press release as well as Eyenovia's quarterly report on Form 10-Q for the second quarter ended September 30th, 2024, which was just filed with the SEC.
The company's press release and annual report are also available on our website at www.eyenovia.com. In addition, this conference call is being webcast on the company's website and will be archived and available for replay for future reference.
Please note that on today's call, we will be discussing products, product concepts, and candidates, some of which have yet to receive FDA approval. Please also note that certain information discussed on the call today is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act.
We caution listeners that during the call, Eyenovia's management will be making forward-looking statements. Actual results could differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business.
These forward-looking statements are subject to a number of risks, which are described in more detail in our annual report on Form 10-K, and subsequent quarterly reports on Form 10-Q.
This conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, November 12th, 2024. Eyenovia undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as may be required by the applicable securities laws.